M. Kathleen Behrens Wilsey's Insider Trades & SAST Disclosures
M. Kathleen Behrens Wilsey's most recent trade in Sarepta Therapeutics Inc was a trade of 4,792 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern M. Kathleen Behrens Wilsey.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 4,792 | 4,792 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 2,383 | 193,476 (0%) | 0% | - | Common Stock | |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 3,078 | 19,280 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 3,078 | 16,202 (0%) | 0% | 0 | Common Stock | |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Sep 2024 | 746 | 191,093 (0%) | 0% | 0 | Common Stock | |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2024 | 15,000 | 0 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.90 per share. | 03 Jul 2024 | 15,000 | 191,839 (0%) | 0% | 13.9 | 208,500 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 3,078 | 13,124 (0%) | 0% | 0 | Common Stock | |
| Mimedx Group Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 7.26 per share. | 05 Jun 2024 | 23,190 | 184,162 (0%) | 0% | 7.3 | 168,359 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 3,078 | 10,046 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 29,400 | 29,400 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 3,679 | 3,679 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 1,846 | 176,839 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | Behrens Wilsey Kathleen M. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 800 | 6,968 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 800 | 5,368 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 26 Jun 2023 | 112,500 | 330,700 (1%) | 0% | 8 | 900,000 | Common Stock |
| Mimedx Group Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 4.95 per share. | 13 Jun 2023 | 35,354 | 160,972 (0%) | 0% | 4.9 | 175,002 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 15,500 | 15,500 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 800 | 4,568 (0%) | 0% | 0 | Common Stock | |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 3,257 | 3,257 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 1,523 | 159,993 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 374 | 3,768 (0%) | 0% | 0 | Common Stock | |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2022 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.92 per share. | 19 Dec 2022 | 20,000 | 158,470 (0%) | 0% | 34.9 | 698,400 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 17.14 per share. | 08 Nov 2022 | 60,000 | 218,200 (0%) | 0% | 17.1 | 1,028,550 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 374 | 3,394 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 374 | 3,020 (0%) | 0% | 0 | Common Stock | |
| Mimedx Group Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 3.96 per share. | 07 Jun 2022 | 44,191 | 125,618 (0%) | 0% | 4.0 | 174,996 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 31 Mar 2022 | 43,478 | 158,200 (0%) | 0% | 23 | 999,994 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 31 Mar 2022 | 8,696 | 29,807 (0%) | 0% | 23 | 200,008 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 23.00 per share. | 31 Mar 2022 | 8,695 | 29,806 (0%) | 0% | 23 | 199,985 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 374 | 2,646 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2022 | 29,497 | 29,497 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 5,077 | 5,077 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2022 | 2,953 | 138,470 (0%) | 0% | 0 | Common Stock | |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.08 per share. | 15 Dec 2021 | 5,000 | 135,517 (0%) | 0% | 10.1 | 50,400 | Common Stock |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2021 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 211 | 2,061 (0%) | 0% | 0 | Common Stock | |
| Mimedx Group Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 10.26 per share. | 27 May 2021 | 17,056 | 81,427 (0%) | 0% | 10.3 | 174,995 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 211 | 94,139 (0%) | 0% | 0 | Common Stock | |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Sale of securities on an exchange or to another person at price $ 85.76 per share. | 10 Mar 2021 | 5,000 | 130,517 (0%) | 0% | 85.8 | 428,800 | Common Stock |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.30 per share. | 10 Mar 2021 | 5,000 | 135,517 (0%) | 0% | 42.3 | 211,500 | Common Stock |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2021 | 5,000 | 0 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 5,518 | 5,518 | - | - | Stock Option (right to buy) | |
| Sarepta Therapeutics Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2021 | 2,726 | 130,517 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 6,423 | 6,423 | - | - | Stock Option (right to buy) | |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 90.00 per share. | 11 Dec 2020 | 22,222 | 22,222 (0%) | 0% | 90 | 1,999,980 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 90.00 per share. | 11 Dec 2020 | 11,111 | 21,111 (0%) | 0% | 90 | 999,990 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 90.00 per share. | 11 Dec 2020 | 11,111 | 21,111 (0%) | 0% | 90 | 999,990 | Common Stock |
| Mimedx Group Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 6.67 per share. | 02 Oct 2020 | 26,236 | 64,371 (0%) | 0% | 6.7 | 174,994 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 357 | 93,571 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 58.75 per share. | 10 Sep 2020 | 5,132 | 71,691 (0%) | 0% | 58.8 | 301,511 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 60.86 per share. | 10 Sep 2020 | 5,033 | 81,166 (0%) | 0% | 60.9 | 306,333 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 59.65 per share. | 10 Sep 2020 | 4,442 | 76,133 (0%) | 0% | 59.6 | 264,948 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 61.80 per share. | 10 Sep 2020 | 4,336 | 85,502 (0%) | 0% | 61.8 | 267,984 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 63.58 per share. | 10 Sep 2020 | 3,351 | 91,644 (0%) | 0% | 63.6 | 213,044 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 63.06 per share. | 10 Sep 2020 | 2,791 | 88,293 (0%) | 0% | 63.1 | 176,004 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 57.75 per share. | 10 Sep 2020 | 2,367 | 66,559 (0%) | 0% | 57.7 | 136,691 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 64.80 per share. | 10 Sep 2020 | 1,570 | 93,214 (0%) | 0% | 64.8 | 101,729 | Common Stock |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Purchase of securities on an exchange or from another person at price $ 56.41 per share. | 10 Sep 2020 | 978 | 64,192 (0%) | 0% | 56.4 | 55,165 | Common Stock |
| Mimedx Group Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2020 | 38,135 | 38,135 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 357 | 63,214 (0%) | 0% | 0 | Common Stock | |
| IGM Biosciences Inc | M. Kathleen Behrens Wilsey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2020 | 357 | 62,857 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges